May your compounding stay potent, your shipments stay cold, and your protocols stay consistent.
Patients with non-alcoholic steatohepatitis (NASH) or non-alcoholic fatty liver disease (NAFLD) with concurrent diabetes or obesity might benefit from the hepatic anti-inflammatory effects observed in clinical studies, though GLP-1 receptor agonists are not yet FDA-approved specifically for liver disease
Reported effects include nausea, facial flushing, skin reactions, and pigment changes, among others
The Liposuction Procedure Traditional liposuction was first introduced decades ago and has had many changes and technical refinements along the way
CASE Richard C, age 50, has type 2 diabetes, hypertension, hyperlipidemia, and obesity
New players such as Beijing Tsinghua Tongfang, Suzhou Yunyin Medical Technology, and Beijing MicroTech Medical are strengthening Chinas microneedle pipeline